What is TrivarX Limited (MDBIF) stock price today?

TrivarX Limited (MDBIF) is currently trading at $0.00.

What is MDBIF P/E ratio?

TrivarX Limited's P/E ratio is -4.57. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is MDBIF return on equity (ROE)?

TrivarX Limited's return on equity (ROE) is -12.07%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is TrivarX Limited's market cap?

TrivarX Limited has a market capitalization of $872787.

OTC · Medical - Healthcare Information Services

TrivarX Limited (MDBIF) Stock

$0.00 OTC: MDBIF Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$872787
P/E Ratio	-4.57
P/B Ratio	0.10
P/S Ratio	-16.94
EPS (TTM)	$0.00
52-Week High	$0.03
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-12.07%
ROA	-7.47%
ROCE	-8.85%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	-100.00%
Debt/Equity	0.01
Current Ratio	5.45

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Operating Profit	$0	$-1.0M	$0	$-2.0M	$0
Net Profit	$-1.0M	$-13.0M	$-3.0M	$-1.0M	$-1.0M
EPS	$-0.02	$-0.12	$-0.02	$0.00	$0.00
Op Margin	2.1%	-50.1%	1.9%	-238.2%	11.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$17.0M	$8.0M	$8.0M	$11.0M	$13.0M
Total Liabilities	$1.0M	$1.0M	$2.0M	$1.0M	$1.0M
Cash	$2.0M	$1.0M	$0	$1.0M	$1.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

We're Keeping An Eye On TrivarX's (ASX:TRI) Cash Burn Rate Simply Wall St. · May 6, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-2.0M	$-2.0M	$-1.0M	$-1.0M	$0
Investing Cash Flow	$-4.0M	$-6.0M	$-5.0M	$-5.0M	$-3.0M
Financing Cash Flow	$0	$0	$0	$0	$3.0M
Net Cash Flow	$1.0M	$-1.0M	$-1.0M	$1.0M	$0
Free Cash Flow	$-4.0M	$-5.0M	$-3.0M	$-3.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.05
EV / EBITDA	-7.36
FCF Yield	-5.81%
Quick Ratio	5.45
Interest Coverage	-132.83
Return 1Y	14.17%
Return 3Y	69.51%
Return 5Y	—

Ownership

Insiders Held25.33%

Institutions Held6.76%

Institutions Float Held9.05%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AIMLFAI/ML Innovations Inc.	$0.03	-1.27%	-1.32	$5.25M	0.00%
CMHSFComprehensive Healthcare Systems, Inc.	$0.29	+0.00%	-2.17	$5.31M	0.00%
FPCGAvem Health Partners, Inc.	$1025.00	+0.00%	1.35	$10.07M	0.00%
MMJJFUnderwood Capital Limited	$0.04	+0.00%	3.67	$8.21M	0.00%
OXBOFOxford BioDynamics Plc	$0.00	—	-0.31	$5.33M	0.00%

About TrivarX Limited

TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.

TrivarX Limited (MDBIF) stock trades at $0.00 with a market capitalization of $872787. The stock is valued at a price-to-earnings (P/E) ratio of -4.57, price-to-book of 0.10, price-to-sales of -16.94. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 100.0% below its 52-week high.

On profitability, TrivarX Limited generates a return on equity (ROE) of -12.07%, return on capital employed of -8.85%, an operating margin of 0.00%, a net profit margin of -100.00%.

Official website: trivarx.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides